The Impact of COVID-19 on Patients With Bradykinin-Mediated Angioedema in the ITACA Cohort.

IF 6.3 2区医学 Q1 ALLERGY

Clinical and Experimental Allergy Pub Date : 2025-05-09 DOI:10.1111/cea.70079

Riccardo Senter, Andrea Zanichelli, Agolini Stefano, Francesco Arcoleo, Donatella Bignardi, Paolo Borrelli, Chiara Cogliati, Caterina Colangelo, Tiziana De Pasquale, Stefano Del Giacco, Davide Firinu, Antonio Gidaro, Mariangela Lo Pizzo, Roberta Parente, Francesca Perego, Angelica Petraroli, Valentina Popescu Janu, Stefano Pucci, Paolina Quattrocchi, Irene Ridolfi, Oliviero Rossi, Federica Ruin, Giuseppe Spadaro, Paola Triggianese, Alessandra Zoli, Massimo Triggiani, Mauro Cancian

引用次数: 0

查看原文本刊更多论文

ITACA队列中COVID-19对缓激肽介导的血管性水肿患者的影响

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Allergy 医学-过敏

CiteScore

10.40

自引率

9.80%

发文量

189

审稿时长

3-8 weeks

期刊介绍： Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part.